方法对比

	匹配的II期临床试验	匹配队列研究
领域	流行病学	流行病学
方法族	Process / pipeline	Process / pipeline
起源年份	1960s–1980s (formalized with Simon optimal designs, 1989)	Mid-20th century; propensity-score variant 1983
提出者	Gehan (1961) for Phase II designs; matching frameworks adapted from case-control methodology	Established practice; propensity-score matching formalized by Rosenbaum & Rubin (1983)
类型	Controlled clinical trial design	Observational analytic study design
开创性文献	Gehan, E. A. (1961). The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13(4), 346–353.	Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
别名	matched Phase II trial, historically matched Phase II study, propensity-matched Phase II trial, externally controlled Phase II trial	matched follow-up study, paired cohort study, propensity-matched cohort, matched prospective study
相关	5	5
摘要	A matched Phase II clinical trial is a single-arm or small-controlled early-efficacy study in which treated patients are paired with matched controls — drawn from historical databases, registries, or concurrent external cohorts — on key prognostic variables such as age, disease stage, and performance status. This design allows preliminary efficacy assessment without a concurrent randomized arm, trading randomization for feasibility while partially controlling for confounding through the matching process.	A matched cohort study is an observational design in which each exposed participant is paired with one or more unexposed counterparts who share key characteristics — such as age, sex, or comorbidity status — before both groups are followed forward in time to compare incident outcomes. Matching controls for measured confounders at the design stage, reducing bias that would otherwise require statistical adjustment alone.